Key Takeaways for Clinicians: Understanding the Delay and Its Implications On February 14, 2025, the Drug Enforcement Administration (DEA) and the Department of Health and
Introduction On February 11, 2025, President Donald Trump nominated Terry Cole to lead the Drug Enforcement Administration (DEA). His appointment is dependent on Senate confirmation.
Healthcare’s Dual Challenge As climate change intensifies, healthcare faces a dual challenge: delivering quality care while reducing its massive carbon footprint. Could telemedicine be the
Introduction Artificial intelligence (AI) is transforming how health services are delivered and experienced, especially in mental healthcare. Whether addressing anxiety, depression, substance use disorders, or
Super Bowl Sunday was thrilling, with a great game, a talked-about halftime show, and, of course, a slew of multimillion-dollar commercials. While some people tuned
Introduction The DEA submitted a rule titled “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” for review on October 10, 2024.
